Willow Biosciences Inc. (WLLW.TO)
CAD 0.04
(0.0%)
CAD 0.04
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.23 Million CAD | 82.47% |
| 2022 | 1.77 Million CAD | -66.74% |
| 2021 | 5.33 Million CAD | -76.21% |
| 2020 | 22.42 Million CAD | 88.83% |
| 2019 | 11.87 Million CAD | 8896.06% |
| 2018 | 132 Thousand CAD | -84.81% |
| 2017 | 869.18 Thousand CAD | -58.27% |
| 2016 | 2.08 Million CAD | 47.86% |
| 2015 | 1.4 Million CAD | 34.6% |
| 2014 | 1.04 Million CAD | 10.18% |
| 2013 | 949.86 Thousand CAD | -23.13% |
| 2012 | 1.23 Million CAD | 140.06% |
| 2011 | 514.7 Thousand CAD | 153.17% |
| 2010 | 203.3 Thousand CAD | -37.11% |
| 2009 | 323.25 Thousand CAD | -64.05% |
| 2008 | 899.22 Thousand CAD | 56.58% |
| 2007 | 574.3 Thousand CAD | -10.81% |
| 2006 | 643.89 Thousand CAD | 10.69% |
| 2005 | 581.73 Thousand CAD | -18.76% |
| 2004 | 716.03 Thousand CAD | -26.99% |
| 2003 | 980.67 Thousand CAD | 27.2% |
| 2002 | 770.95 Thousand CAD | 9.57% |
| 2001 | 703.62 Thousand CAD | 27.73% |
| 2000 | 550.86 Thousand CAD | 113.61% |
| 1999 | 257.88 Thousand CAD | 79.77% |
| 1998 | 143.44 Thousand CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 3.03 Million CAD | -6.39% |
| 2024 Q2 | 3.63 Million CAD | 19.87% |
| 2023 Q2 | 2.94 Million CAD | 69.76% |
| 2023 Q4 | 3.23 Million CAD | 16.65% |
| 2023 Q1 | 1.73 Million CAD | -2.14% |
| 2023 Q3 | 2.77 Million CAD | -5.84% |
| 2023 FY | 3.23 Million CAD | 82.47% |
| 2022 Q4 | 1.77 Million CAD | 64.26% |
| 2022 Q2 | 1.71 Million CAD | -45.01% |
| 2022 FY | 1.77 Million CAD | -66.74% |
| 2022 Q1 | 3.12 Million CAD | -41.43% |
| 2022 Q3 | 1.08 Million CAD | -37.14% |
| 2021 Q3 | 6.69 Million CAD | -59.17% |
| 2021 FY | 5.33 Million CAD | -76.21% |
| 2021 Q1 | 29.12 Million CAD | 29.88% |
| 2021 Q2 | 16.39 Million CAD | -43.69% |
| 2021 Q4 | 5.33 Million CAD | -20.34% |
| 2020 Q2 | 8.87 Million CAD | 5.35% |
| 2020 Q4 | 22.42 Million CAD | 80.52% |
| 2020 Q1 | 8.42 Million CAD | -29.03% |
| 2020 Q3 | 12.42 Million CAD | 39.91% |
| 2020 FY | 22.42 Million CAD | 88.83% |
| 2019 Q1 | 1.07 Million CAD | -6.02% |
| 2019 Q3 | 13.89 Million CAD | -19.05% |
| 2019 Q2 | 17.16 Million CAD | 1496.23% |
| 2019 Q4 | 11.87 Million CAD | -14.55% |
| 2019 FY | 11.87 Million CAD | 8896.06% |
| 2018 FY | 132 Thousand CAD | -84.81% |
| 2018 Q1 | 753.31 Thousand CAD | 3.3% |
| 2018 Q3 | 1.03 Million CAD | 18.52% |
| 2018 Q4 | 1.14 Million CAD | 11.08% |
| 2018 Q2 | 869.18 Thousand CAD | 15.38% |
| 2017 Q4 | 729.22 Thousand CAD | -67.16% |
| 2017 Q3 | 2.22 Million CAD | 6.6% |
| 2017 Q2 | 2.08 Million CAD | 12.22% |
| 2017 Q1 | 1.85 Million CAD | 10.06% |
| 2017 FY | 869.18 Thousand CAD | -58.27% |
| 2016 Q1 | 1.29 Million CAD | 11.29% |
| 2016 FY | 2.08 Million CAD | 47.86% |
| 2016 Q3 | 1.55 Million CAD | 10.04% |
| 2016 Q4 | 1.68 Million CAD | 8.79% |
| 2016 Q2 | 1.4 Million CAD | 9.17% |
| 2015 Q3 | 1.02 Million CAD | -2.48% |
| 2015 Q1 | 856.24 Thousand CAD | 14.58% |
| 2015 Q2 | 1.04 Million CAD | 22.22% |
| 2015 FY | 1.4 Million CAD | 34.6% |
| 2015 Q4 | 1.15 Million CAD | 13.61% |
| 2014 Q1 | 968.57 Thousand CAD | 12.8% |
| 2014 Q3 | 617.01 Thousand CAD | -35.04% |
| 2014 Q4 | 747.29 Thousand CAD | 21.11% |
| 2014 Q2 | 949.86 Thousand CAD | -1.93% |
| 2014 FY | 1.04 Million CAD | 10.18% |
| 2013 Q2 | 1.23 Million CAD | 10.52% |
| 2013 FY | 949.86 Thousand CAD | -23.13% |
| 2013 Q1 | 1.11 Million CAD | 18.64% |
| 2013 Q4 | 858.66 Thousand CAD | -15.24% |
| 2013 Q3 | 1.01 Million CAD | -18.01% |
| 2012 Q4 | 942.37 Thousand CAD | 22.39% |
| 2012 FY | 1.23 Million CAD | 140.06% |
| 2012 Q1 | 357.23 Thousand CAD | 4.93% |
| 2012 Q2 | 514.7 Thousand CAD | 44.08% |
| 2012 Q3 | 770 Thousand CAD | 49.6% |
| 2011 FY | 514.7 Thousand CAD | 153.17% |
| 2011 Q4 | 340.43 Thousand CAD | 5.35% |
| 2011 Q2 | 203.3 Thousand CAD | 27.06% |
| 2011 Q1 | 160 Thousand CAD | -1.15% |
| 2011 Q3 | 323.15 Thousand CAD | 58.95% |
| 2010 FY | 203.3 Thousand CAD | -37.11% |
| 2010 Q1 | 713.82 Thousand CAD | 0.32% |
| 2010 Q2 | 323.25 Thousand CAD | -54.71% |
| 2010 Q3 | 476.59 Thousand CAD | 47.43% |
| 2010 Q4 | 161.86 Thousand CAD | -66.04% |
| 2009 Q3 | 843.9 Thousand CAD | -6.15% |
| 2009 FY | 323.25 Thousand CAD | -64.05% |
| 2009 Q1 | 366.06 Thousand CAD | 1.77% |
| 2009 Q4 | 711.55 Thousand CAD | -15.68% |
| 2009 Q2 | 899.22 Thousand CAD | 145.65% |
| 2008 Q1 | 368 Thousand CAD | 6.84% |
| 2008 Q2 | 574.3 Thousand CAD | 56.06% |
| 2008 Q3 | 625.84 Thousand CAD | 8.98% |
| 2008 Q4 | 359.69 Thousand CAD | -42.53% |
| 2008 FY | 899.22 Thousand CAD | 56.58% |
| 2007 FY | 574.3 Thousand CAD | -10.81% |
| 2007 Q4 | 344.45 Thousand CAD | -35.77% |
| 2007 Q3 | 536.31 Thousand CAD | -16.71% |
| 2007 Q2 | 643.89 Thousand CAD | 5.78% |
| 2007 Q1 | 608.71 Thousand CAD | -1.42% |
| 2006 Q2 | 581.73 Thousand CAD | 6.53% |
| 2006 Q3 | 634.16 Thousand CAD | 9.01% |
| 2006 Q4 | 617.5 Thousand CAD | -2.63% |
| 2006 FY | 643.89 Thousand CAD | 10.69% |
| 2006 Q1 | 546.07 Thousand CAD | -18.32% |
| 2005 Q1 | 270.03 Thousand CAD | -58.96% |
| 2005 Q2 | 716.03 Thousand CAD | 165.16% |
| 2005 Q4 | 668.52 Thousand CAD | -9.97% |
| 2005 Q3 | 742.56 Thousand CAD | 3.71% |
| 2005 FY | 581.73 Thousand CAD | -18.76% |
| 2004 FY | 716.03 Thousand CAD | -26.99% |
| 2004 Q1 | 825.85 Thousand CAD | 1.92% |
| 2004 Q2 | 980.67 Thousand CAD | 18.75% |
| 2004 Q3 | 1.01 Million CAD | 3.6% |
| 2004 Q4 | 658.05 Thousand CAD | -35.23% |
| 2003 Q3 | 787.05 Thousand CAD | 2.09% |
| 2003 Q4 | 810.25 Thousand CAD | 2.95% |
| 2003 Q1 | 752.31 Thousand CAD | 2.64% |
| 2003 FY | 980.67 Thousand CAD | 27.2% |
| 2003 Q2 | 770.95 Thousand CAD | 2.48% |
| 2002 Q1 | 684.91 Thousand CAD | 54.27% |
| 2002 FY | 770.95 Thousand CAD | 9.57% |
| 2002 Q4 | 732.97 Thousand CAD | 3.42% |
| 2002 Q3 | 708.73 Thousand CAD | 0.73% |
| 2002 Q2 | 703.62 Thousand CAD | 2.73% |
| 2001 Q2 | 550.86 Thousand CAD | 41.47% |
| 2001 FY | 703.62 Thousand CAD | 27.73% |
| 2001 Q1 | 389.39 Thousand CAD | 20.54% |
| 2001 Q3 | 601.69 Thousand CAD | 9.23% |
| 2001 Q4 | 443.96 Thousand CAD | -26.21% |
| 2000 Q4 | 323.02 Thousand CAD | 11.83% |
| 2000 FY | 550.86 Thousand CAD | 113.61% |
| 2000 Q3 | 288.87 Thousand CAD | 0.0% |
| 1999 FY | 257.88 Thousand CAD | 79.77% |
| 1998 FY | 143.44 Thousand CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aurora Cannabis Inc. | 236.8 Million CAD | 98.633% |
| Avicanna Inc. | 13.99 Million CAD | 76.877% |
| Avant Brands Inc. | 33.22 Million CAD | 90.257% |
| Cardiol Therapeutics Inc. | 8.45 Million CAD | 61.71% |
| Crescita Therapeutics Inc. | 5.77 Million CAD | 43.958% |
| Knight Therapeutics Inc. | 198.62 Million CAD | 98.37% |
| MediPharm Labs Corp. | 10.93 Million CAD | 70.39% |
| OrganiGram Holdings Inc. | 26.83 Million CAD | 87.936% |
| Canopy Growth Corporation | 799.82 Million CAD | 99.595% |
| Auxly Cannabis Group Inc. | 210.85 Million CAD | 98.465% |